These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20071864)

  • 21. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy.
    Jain JK; Dutton C; Harwood B; Meckstroth KR; Mishell DR
    Hum Reprod; 2002 Jun; 17(6):1477-82. PubMed ID: 12042265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison or oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion.
    Mittal S; Agarwal S; Kumar S; Batra A
    Indian J Med Res; 2005 Aug; 122(2):132-6. PubMed ID: 16177470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases.
    Ashok PW; Templeton A
    Br J Obstet Gynaecol; 1999 Jul; 106(7):706-10. PubMed ID: 10428528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent use of mifepristone and misoprostol for early medical abortion.
    Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation.
    Fox MC; Creinin MD; Harwood B
    Contraception; 2002 Oct; 66(4):225-9. PubMed ID: 12413616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.
    Okonofua F; Shittu O; Shochet T; Diop A; Winikoff B
    Int J Gynaecol Obstet; 2014 Apr; 125(1):49-52. PubMed ID: 24507887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh.
    Cameron ST; Glasier AF; Logan J; Benton L; Baird DT
    Br J Obstet Gynaecol; 1996 Dec; 103(12):1222-9. PubMed ID: 8968240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for surgical intervention of early medical abortion.
    Meaidi A; Friedrich S; Gerds TA; Lidegaard O
    Am J Obstet Gynecol; 2019 May; 220(5):478.e1-478.e15. PubMed ID: 30763542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
    Goh SE; Thong KJ
    Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter trial of a simplified mifepristone medical abortion regimen.
    Shannon CS; Winikoff B; Hausknecht R; Schaff E; Blumenthal PD; Oyer D; Sankey H; Wolff J; Goldberg R
    Obstet Gynecol; 2005 Feb; 105(2):345-51. PubMed ID: 15684163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First trimester abortion with mifepristone and three doses of sublingual misoprostol: a pilot study.
    Singh KC; Ummat S; Rajaram S; Goel N
    Aust N Z J Obstet Gynaecol; 2005 Dec; 45(6):495-8. PubMed ID: 16401215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mifepristone and misoprostol for medical termination of pregnancy: the effectiveness of a flexible regimen.
    Basu R; Gundlach T; Tasker M
    J Fam Plann Reprod Health Care; 2003 Jul; 29(3):139-41. PubMed ID: 12885307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
    Faucher P; Baunot N; Madelenat P
    Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
    Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B
    BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost.
    Bartley J; Tong S; Everington D; Baird DT
    Contraception; 2000 Dec; 62(6):297-303. PubMed ID: 11239616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens.
    Heikinheimo O; Leminen R; Suhonen S
    Contraception; 2007 Dec; 76(6):456-60. PubMed ID: 18061704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
    Gatter M; Cleland K; Nucatola DL
    Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early versus late misoprostol administration after mifepristone for medical abortion.
    Tendler R; Bornstein J; Kais M; Masri I; Odeh M
    Arch Gynecol Obstet; 2015 Nov; 292(5):1051-4. PubMed ID: 25911546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion.
    Creinin MD; Potter C; Holovanisin M; Janczukiewicz L; Pymar HC; Schwartz JL; Meyn L
    Am J Obstet Gynecol; 2003 Mar; 188(3):664-9. PubMed ID: 12634638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks gestation.
    Tang OS; Xu J; Cheng L; Lee SW; Ho PC
    Hum Reprod; 2002 Jul; 17(7):1738-40. PubMed ID: 12093832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.